Proteomic Identification of Pathways Responsible for the Estradiol Therapeutic Window in AD Animal Models

Proteomic Identification of Pathways Responsible for the Estradiol Therapeutic Window in AD Animal Models

Benefits and risks were reported for hormone therapy (HT) to prevent chronic disease, including Alzheimer’s disease (AD). While the Women’s Health Initiative (WHI) found no protective effect of HT on the cognitive function of women whose treatment was initiated far past the onset of menopause, other...

Full description

Bibliographic Details
Main Authors: Jie Cui, Jon Reed, Gogce Crynen, Ghania Ait-Ghezala, Fiona Crawford, Yong Shen, Rena Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Alzheimer’s disease
β-amyloid
cognition
hormone therapy
estrogen
Online Access:https://www.frontiersin.org/article/10.3389/fncel.2019.00437/full

Internet

https://www.frontiersin.org/article/10.3389/fncel.2019.00437/full

Similar Items